Successful treatment of influenza a virus by oseltamivir in bone marrow transplant recipients

Pediatric Transplantation

Volumn 14, Issue 2, 2010, Pages 178-181

  Mellouli, F ^a   Ouederni, M ^a   Dhouib, N ^a   Hajkacem, M A ^b   Slim, A ^b   Bejaoui, M ^a  

^a CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Bone marrow transplantation; Influenza A; Oseltamivir

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; OSELTAMIVIR; THYMOCYTE ANTIBODY; VIRUS ANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BARE LYMPHOCYTE SYNDROME; BONE MARROW APLASIA; CASE REPORT; CHEMOTHERAPY INDUCED EMESIS; CHILD; CLINICAL FEATURE; CORTICOSTEROID THERAPY; COUGHING; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG TOLERABILITY; ENGRAFTMENT; FEMALE; FEVER; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOFLUORESCENCE; INFECTION CONTROL; INFLUENZA VIRUS A; LEUKOCYTE ADHESION DEFICIENCY; LOWER RESPIRATORY TRACT INFECTION; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG LAVAGE; MALE; NASOPHARYNGEAL ASPIRATION; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; RHINITIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION;

EID: 76449112992     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01114.x     Document Type: Article

References (20)

1. Martino R, Porras RP, Rabella N, et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005 : 11 : 781 796.
2. Ljungman P. Respiratory virus infections in stem cell transplant patients: The European experience. Biol Blood Marrow Transplant 2001 : 7 : 5S 7S.
3. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001 : 20 : 127 133.
4. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial. Lancet 2000 : 355 : 1845 1850.
5. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000 : 283 : 1016 1024.
6. Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. J Infect 2008 : 56 : 51 57.
7. Lujan-Zilbermann J, Benaim E, Tong X, Srivastava DK, Patrick CC, DeVincenzo JP. Respiratory virus infections in pediatric hematopoietic stem cell transplantation. Clin Infect Dis 2001 : 33 : 962 968.
8. Machado CM, Boas LS, Mendes AV, et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003 : 31 : 695 700.
9. Machado CM, Boas LS, Mendes AV, et al. Use of oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004 : 34 : 111 114.
10. Whimbey E, Elting LS, Couch RB, et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994 : 13 : 437 440.
11. Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001 : 28 : 479 484.
12. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004 : 39 : 1300 1306.
13. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003 : 163 : 1667 1672.
14. McGeer A, Green K, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007 : 45 : 1568 1575.
15. Scott JD, Englund JA, Myerson D, Geballe AP. Influenza A pneumonia presenting as progressive focal infiltrates in a stem cell transplant recipient. J Clin Virol 2004 : 31 : 96 99.
16. Medeiros R, Rameix-Welti MA, Lorin V, et al. Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus. Antivir Ther 2007 : 12 : 571 576.
17. Englund JA, Champlin RE, Wyde PR, et al. Common emergence of amantadine and rimantidine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 1998 : 26 : 1418 1424.
18. Fine LS, Gibson G, Graman PS. Tolerability and efficacy of oseltamivir for managing an influenza A outbreak in an inpatient Hematology/Oncology Unit. AJIC 2005 : 35 : E120.
19. Chik KW, Li CK, Chan PKS, et al. Oseltamivir prophylaxis during the influenza season in a paediatric cancer center: Prospective observational study. Hong Kong Med J 2004 : 10 : 103 106.
20. Welliver R, Monto AS, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: A randomized controlled trial. JAMA 2001 : 285 : 748 754.